Title and introductory text
This Statutory Instrument supersedes S.I. 2024/239 which was laid before Parliament and published on 29th February 2024. It is being issued free of charge to all known recipients of that Statutory Instrument.
2024 No. 248
Dangerous Drugs
The Misuse of Drugs and Misuse of Drugs (Designation) (England and Wales and Scotland) (Amendment and Revocation) Regulations 2024
Made
at 10.00 a.m. on 29th February 2024
Laid before Parliament
at 2.00 p.m. on 29th February 2024
Coming into force
Regulations 1 and 4
19th March 2024
Remainder
20th March 2024
The Secretary of State makes these Regulations in exercise of the powers conferred by sections 7(1), (4) and (5), 10(1) and 31(1)(a) of the Misuse of Drugs Act 1971.
In accordance with sections 7(7) and 31(3) of that Act the Secretary of State has consulted the Advisory Council on the Misuse of Drugs.
Propose a change2 Amendment of the Misuse of Drugs Regulations 2001
(1) The following amendments are made to the Misuse of Drugs Regulations 2001.
(2) In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27)—
(a) after “Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Brorphine”;
(b) after “Bufotenine” insert “Butonitazene”;
(c) after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Clonitazene”;
(d) after “Concentrate of poppy-straw” insert “Cumyl-PeGaClone”;
(e) after “3-Dimethylheptyl-11-hydroxyhexahydrocannabinol” insert—
Diphenidine
Ephenidine
Ethyleneoxynitazene
;
(f) after “Etizolam” insert—
Etodesnitazene (etazene)
Etonitazene
;
(g) after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitazene”;
(h) after “Isopropylphenidate (IPP or IPPD)” insert “Isotonitazene”;
(i) after “Methcathinone” insert “Methoxyphenidine”;
(j) after “Metizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)” insert—
Metodesnitazene (metazene)
Metonitazene
;
(k) after “Propylphenidate” insert “Protonitazene”;
(l) after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)” insert—
N-Desethyl etonitazene
N-Desethylisotonitazene
N-Desethyl protonitazene
;
(m) after “4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)” insert—
N-Piperidinyl-etonitazene (etonitazepipne)
N-Pyrrolidino-etonitazene (etoniazepyne)
N-Pyrrolidino protonitazene
.
(3) In paragraph 1 of Schedule 2 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 16A, 18, 19, 20, 21, 23, 26 and 27) omit “Clonitazene” and “Etonitazene”.
(4) In paragraph 1 of Part 1 of Schedule 4 (which specifies controlled drugs subject to the requirements of regulations 22, 23, 26 and 27) after “Pyrovalerone” insert “Remimazolam”.
Propose a change3 Amendment of the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015
(1) The following amendments are made to Schedule 1 to the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015 (which specifies controlled drugs to which section 7(4) of the Misuse of Drugs Act 1971 applies).
(2) In paragraph 1(a)—
(a) after “Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Brorphine”;
(b) after “1,4-Butanediol” insert “Butonitazene”;
(c) after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Clonitazene”;
(d) after “Concentrate of poppy-straw” insert “Cumyl-PeGaClone”;
(e) after “Diclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one)” insert—
Diphenidine
Ephenidine
Ethyleneoxynitazene
;
(f) after “Etizolam” insert—
Etodesnitazene (etazene)
Etonitazene
;
(g) after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitazene”;
(h) after “Isopropylphenidate (IPP or IPPD)” insert “Isotonitazene”;
(i) after “Methcathinone” insert “Methoxyphenidine”;
(j) after “Metizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)” insert—
Metodesnitazene (metazene)
Metonitazene
;
(k) after “Propylphenidate” insert “Protonitazene”;
(l) after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)” insert—
N-Desethyl etonitazene
N-Desethylisotonitazene
N-Desethyl protonitazene
;
(m) after “4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)” insert—
N-Piperidinyl-etonitazene (etonitazepipne)
N-Pyrrolidino-etonitazene (etoniazepyne)
N-Pyrrolidino protonitazene
.
Propose a change